Scoli-Risk-1 study wins the Russell A Hibbs Clinical Award

26. September 2013

An AOSpine study conducted with the Scoliosis Research Society makes its mark at a scientific congress.

Scoli-Risk-1-Award_article_top_2013.jpg 

The Scoli-Risk-1 study is designed to evaluate neurologic complications associated with surgical correction of adult spinal deformity. This prospective, observational, multicenter study marks the first clinical trial collaboration between AOSpine and the Scoliosis Research Society (SRS). AO Clinical Investigation and Documentation is running this complex study on behalf of AOSpine and the SRS across three continents. The project is now in the final data analysis phase.

The Russell A Hibbs Awards are given to both the best basic science and clinical papers presented at the SRS Annual Meeting. The 48th SRS annual meeting was held in September in Lyon, France, where over 120 scientific presentations were made.

The AO Foundation is happy to announce that the presentation by Larry Lenke, based on the abstract written by LG Lenke, MG Fehlings, Ch Shaffrey, KM Cheung, and LY Carreon, entitled Prospective, Multicenter Assessment of Acute Neurologic Complications Following Complex Adult Spinal Deformity Surgery: The Scoli-Risk-1 Trial received the Russell A Hibbs Award for the best clinical research presentation.

This is a great achievement and serves as recognition of the impact of the SRS-AOSpine collaboration.

Congratulations to the entire team behind the Scoli-Risk-1 Trial, and in particular to Larry Lenke (Principal Investigator-PI), Michael Fehlings (Co-PI), the rest of the Executive Committee, the 15 Site PI’s, and the 45 surgeons participating in this landmark study.​

 

​​​​